world meetings |
||||||
|
News for 02-Dec-24 Source: MedicineNet Diabetes General Source: MedicineNet Diabetes General Source: MedicineNet Diabetes General Source: MedicineNet Diabetes General Source: MedicineNet High Blood Pressure General Source: MedicineNet Diabetes General Source: MedicineNet Diabetes General Source: MedicineNet High Blood Pressure General Source: MedicineNet High Blood Pressure General Source: MedicineNet High Blood Pressure General
|
The Best world meetings websiteAll the world meetings information you need to know about is right
here. Presented and researched by http://www.mdnewscast.net. We've searched
the information super highway far and wide to provide you with the
best world meetings site on the internet today. The links below will
assist you in your efforts to find the information that you are looking
for about
world meetings
A treasure chest of world meetings information.There is no doubt you and I have a great interest in world meetings after all that's why you arrived at this web page and it's why I created this world meetings web site. I'm actually passionate about world meetings and in time will make the site one of the best resources for information. You can search around for hours looking for good world meetings sites but as you have no doubt found, many of the sites that rank well in search engines for world meetings are pretty hopeless. While your visit to my site is a little premature because I'm still working on it, in the not too distant future it will become one of the best sites on the net for world meetings. I'm aware of the needs of people searching the net for world meetings information and I plan to create a directory of valuable links to world meetings sites. Every site I list, such as the examples below will carry recommended reading and I'm sure every visitor will be delighted with what they find. Here's just a small example of the links you will find in the future, I'm sure if you visit the site you will not be disappointed. Right now I'm working on making my world meetings site bigger and better, it's turning out to be a much largerr task than I expected, but because I am passionate about world meetings I work with great purpose so it's not really work. I invite you to call back sometime and I'm sure I'll have it completed and maybe you can pass on my url to your friends that have similar world meetings interests. world meetings
If you follow one of the above world meetings hyperlinks, or take a look at the website that might have popped up when you entered my, not yet so fantastic site, you'll see what I mean. These world meetings sites are so useful that they put my little effort to shame. Seeing I'm not exactly flushed with content yet, you may as well leave my little website now to visit one of the world meetings sites I've linked to. But before you do go I'd just like to say that I'm putting lots of work and effort into this world meetings place of mine and I'd be pleased if you'd remember it and come back again one day soon. a Cold; Starve a Tumor by: ARA Content
(ARA) - One of the most exciting developments in modern medicine has been the discovery that cancerous tumors have the potential of being "starved" out of existence, or at least into dormancy. Scientists, doctors and, of course, patients, are all anticipating the prospect that cancer patients may take a drug that will stop a tumor in its track by cutting off the blood supply that nourishes it. At the core of this medical breakthrough was the discovery that every tumor needs to "recruit" its own blood supply to flourish and grow. Scientists also found out that tumors actively "participated" in this process by secreting certain growth chemicals that would attract blood vessels to the tumor. Having identified this process, the next step was to determine if drugs could be created that could somehow arrest or reverse the progress of blood vessels amassing around a tumor. The result has been a highly dynamic and exciting area of medicine called anti-angiogenesis (meaning "against the formation of new blood vessels") that focuses on inhibiting the growth of cancer by developing drugs that will prevent tumors from growing in size. Currently, there are several drug companies that are on the cusp of introducing drugs that will work by the process of anti-angiogenesis. Generally speaking, the drugs seek to improve survival rates of cancer patients, as well as increase the length of time that patients survive. And unlike conventional cancer therapies that have punishing side effects, the new drugs seem to demonstrate few or no side effects for most people. Furthermore, some of the studies show that by utilizing both conventional treatments like radiation and/or chemotherapy in conjunction with anti-angiogenesis drugs, the cumulative effect is even more powerful. One highly regarded company that is at the forefront of developing anti-angiogenesis drugs is Aeterna Laboratories, based in Quebec, Canada and traded on the Nasdaq market under the ticker symbol, AELA. The company's premier product, Neovastat, is currently being tested in clinical trials for a variety of cancers including lung, renal (kidney) and multiple myeloma (bone marrow). The results for the renal and multiple myeloma tests are scheduled to wrap up by the end of 2002 and, if conclusive, will be submitted to the Federal Drug Administration for review. Out of all the drugs under development, Neovastat is unique because of its multi-functionality, which is its ability to shut down two pathways recognized as being responsible for promoting angiogenesis (in contrast to other drugs which just block one pathway). In clinical trials, Neovastat has been shown to have no side effects in most people. This is obviously a big advantage for people who know the agony of nausea, exhaustion and/or hair loss that can accompany chemotherapy drugs. In tests, Neovastat has been given to people in liquid oral form, generally the preferable form of drug delivery for patients. If you are a cancer patient interested in clinical trial participation, you can get information about current trials by calling (888)-349-3232 If you are an oncologist, please contact Claude Hariton, Ph.D., vice president of Clinical and Regulatory Affairs at (418) 652-8525 ext. 306. To learn more about anti-angiogenesis drugs and Aeterna Laboratories, visit the Aeterna Web site at www.aeterna.com.
|
|||||
|
http://www.medmeet.com/ |
||||||
| Medical Newscast Fantasy Football Information Medical Presentations |